Q4 2024 Earnings Call Transcript February 10, 2025 Vertex Pharmaceuticals Incorporated misses on earnings expectations. Reported EPS is $3.98 EPS, expectations were $4.02. Operator: Good day, and ...

Operator Good day, and welcome to the Vertex Pharmaceuticals fourth quarter 2024 earnings call. All participants will be in a ...

India stormed to a resounding 150-run win in the fifth T20I ... Keep updated, follow The Business Standard's Google news channel The carnage didn't stop after the fielding restrictions were lifted.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

A new offer from a high street banking giant could see a free £150 landing in the accounts of new and existing customers - and all they have to do is make a simple switch. Santander is tempting ...

Vertex has hit the ground running with Casgevy, its gene therapy for blood disorders. Moreover, its experimental cell therapy for type 1 diabetes, Zimislecel (formerly VX-880), has shown ...

And if analysts are to be believed, there is no respite in sight yet. While the Nifty Midcap 150 index has lost around 7 per cent thus far in CY25, the Nifty Smallcap 250 index has slipped around 9 ...

HOUSTON, January 22, 2025--(BUSINESS WIRE)--Vertex Energy, Inc. ("Vertex" or the "Company"), a leading specialty refiner and marketer of high-quality refined products, together with its affiliates ...